Market Tracker

02/27 8:21am ET

Protalix Biotherapeutics Inc (NYSE MKT LLC:PLX)

1.12
Delayed Data
As of Feb 24
 +0.07 / +6.67%
Today’s Change
0.26
Today|||52-Week Range
1.48
+151.69%
Year-to-Date
No recent news for Protalix Biotherapeutics Inc.

Today’s Trading

Previous close1.05
Today’s open1.04
Day’s range1.00 - 1.13
Volume3,067,877
Average volume (3 months)2,793,566
Market cap$111.9M
Dividend yield--
Data as of 02/24/2017

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)--
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)-71.21%
P/E ratioNM
Price/Sales22.19
Price/Book10.28

Competitors

 Today’s
change
Today’s
% change
ADVMAdverum Biotechnolog...-0.10-3.64%
PSTIPluristem Therapeuti...-0.01-0.88%
GNCAGenocea Biosciences ...-0.09-1.92%
CFRXContraFect Corp+0.02+0.71%
Data as of 4:00pm ET, 02/24/2017

Financials

Next reporting dateMarch 16, 2017
EPS forecast (this quarter)-$0.11
Annual revenue (last year)$4.4M
Annual profit (last year)$18.1M
Net profit margin-625.16%

Profile

Sector
Health Services
Industry
Services to the Health Industry
President, Chief Executive Officer &
Director
Moshe Manor
Chief Operating Officer
Tzvi Palash
Corporate headquarters
Carmiel, Haifa

Forecasts